| General Information of Drug Metabolite (DM) (ID: DM019567) |
| DM Name |
PD-153035 M1
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2D (CYP2D)
|
DMEN826
|
| Oxidation - N-oxidation |
PD-153035
|
[1] |
|
Cytochrome P450 3A (CYP3A)
|
DMEN065
|
| Oxidation - N-oxidation |
PD-153035
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| PD-153035 |
DR2901
|
Discontinued in Phase 1 |
Psoriasis vulgaris |
|
|
| References |
| 1 |
Metabolism of epidermal growth factor receptor targeting probe [11C]PD153035: impact on biodistribution and tumor uptake in rats
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
